GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Science Strategic Acquisition Corp Alpha (NAS:SSAAU) » Definitions » Cash Ratio

Science Strategic Acquisition Alpha (Science Strategic Acquisition Alpha) Cash Ratio : 0.16 (As of Sep. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Science Strategic Acquisition Alpha Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Science Strategic Acquisition Alpha's Cash Ratio for the quarter that ended in Sep. 2022 was 0.16.

Science Strategic Acquisition Alpha has a Cash Ratio of 0.16. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.

The historical rank and industry rank for Science Strategic Acquisition Alpha's Cash Ratio or its related term are showing as below:

SSAAU' s Cash Ratio Range Over the Past 10 Years
Min: 0.16   Med: 0.64   Max: 7.13
Current: 0.16

During the past 2 years, Science Strategic Acquisition Alpha's highest Cash Ratio was 7.13. The lowest was 0.16. And the median was 0.64.

SSAAU's Cash Ratio is not ranked
in the Diversified Financial Services industry.
Industry Median: 1.175 vs SSAAU: 0.16

Science Strategic Acquisition Alpha Cash Ratio Historical Data

The historical data trend for Science Strategic Acquisition Alpha's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Science Strategic Acquisition Alpha Cash Ratio Chart

Science Strategic Acquisition Alpha Annual Data
Trend Dec20 Dec21
Cash Ratio
0.11 0.21

Science Strategic Acquisition Alpha Quarterly Data
Oct20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Cash Ratio Get a 7-Day Free Trial 1.20 0.21 0.18 0.22 0.16

Competitive Comparison of Science Strategic Acquisition Alpha's Cash Ratio

For the Shell Companies subindustry, Science Strategic Acquisition Alpha's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Science Strategic Acquisition Alpha's Cash Ratio Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Science Strategic Acquisition Alpha's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Science Strategic Acquisition Alpha's Cash Ratio falls into.



Science Strategic Acquisition Alpha Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Science Strategic Acquisition Alpha's Cash Ratio for the fiscal year that ended in Dec. 2021 is calculated as:

Cash Ratio (A: Dec. 2021 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=0.346/1.636
=0.21

Science Strategic Acquisition Alpha's Cash Ratio for the quarter that ended in Sep. 2022 is calculated as:

Cash Ratio (Q: Sep. 2022 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=0.445/2.714
=0.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Science Strategic Acquisition Alpha  (NAS:SSAAU) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Science Strategic Acquisition Alpha Cash Ratio Related Terms

Thank you for viewing the detailed overview of Science Strategic Acquisition Alpha's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Science Strategic Acquisition Alpha (Science Strategic Acquisition Alpha) Business Description

Traded in Other Exchanges
N/A
Address
1447 2nd Street, Suite 200, Santa Monica, CA, USA, 90401
Science Strategic Acquisition Corp Alpha is a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
Executives
Michael Gwynne Jones director, officer: CEO 24460 MALIBU ROAD, MALIBU CA 90265
Jeff Kearl director C/O SKULLCANDY, INC., 1441 WEST UTE BLVD., SUITE 250, PARK CITY UT 84908
April Henry officer: EVP, Corporate Development C/O SCIENCE STRATEGIC ACQUISITION CORP., 1447 2ND STREET, SANTA MONICA CA 90401
Jennifer Rubio director C/O TISHMAN SPEYER PROPERTIES, L.P., ROCKEFELLER CENTER, 45 ROCKEFELLER PLAZA, NEW YORK NY 10111
Taylor Colette K. director C/O SCIENCE STRATEGIC ACQUISITION CORP., 1447 2ND STREET, SANTA MONICA CA 90401
Greg Gilman director C/O SCIENCE STRATEGIC ACQUISITION CORP., 1447 2ND STREET, SANTA MONICA CA 90401
Priscilla Guevara officer: Global Head of IR C/O SCIENCE STRATEGIC ACQUISITION CORP., 1447 2ND STREET, SANTA MONICA CA 90401
Tom Dare officer: CFO C/O SCIENCE STRATEGIC ACQUISITION CORP., 1447 2ND STREET, SANTA MONICA CA 90401
Peter Pham officer: President C/O SCIENCE STRATEGIC ACQUISITION CORP., 1447 2ND STREET, SANTA MONICA CA 90401

Science Strategic Acquisition Alpha (Science Strategic Acquisition Alpha) Headlines

No Headlines